Anti-Angiogenic Alternatives to VEGF Blockade

Clinical and Experimental Metastasis - Netherlands
doi 10.1007/s10585-015-9769-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

VEGF Trap Complex Formation Measures Production Rates of VEGF, Providing a Biomarker for Predicting Efficacious Angiogenic Blockade

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Bufalin Enhances Anti-Angiogenic Effect of Sorafenib via AKT/VEGF Signaling

International Journal of Oncology
Cancer ResearchOncology
2016English

Inhibition of VEGF Expression Through Blockade of Hif1α and STAT3 Signalling Mediates the Anti-Angiogenic Effect of Melatonin in HepG2 Liver Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2013English

Computational Models of VEGF-associated Angiogenic Processes in Cancer

Mathematical Medicine and Biology
GeneticsPharmacologyMolecular BiologyEnvironmental ScienceBiochemistryApplied MathematicsMicrobiology SimulationImmunologyNeuroscienceMedicineModeling
2011English

Anti-Angiogenic Therapy: From Laboratory to the Patient

Breast Cancer Online
2009English

Imatinib May Be ABL to Improve Anti-Angiogenic Therapy

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2015English

The Angiogenic Secretome in VEGF Overexpressing Breast Cancer Xenografts

Scientific Reports
Multidisciplinary
2016English

Soluble VEGF Receptor-2 May Be a Predictive Marker of Anti-Angiogenic Therapy With Clinically Available Safe Agents

Oncology Letters
Cancer ResearchOncology
2010English

Computational Systems Biology Approaches to Anti-Angiogenic Cancer Therapeutics

Drug Discovery Today
Drug DiscoveryPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy